Zybio ha comenzado a involucrarse en la producción de biomateriales debido a su espectacular expansión a nivel nacional en los últimos años. Se fundó un centro independiente de investigación y desarrollo de biomateriales para la producción de una variedad de biomateriales, como antígenos y anticuerpos, para garantizar y controlar la calidad de nuestros productos.
Nuestros antígenos (nativos o recombinantes) y anticuerpos (monoclonales o policlonales) están validados para su aplicación en la mayoría de las tecnologías que se aplican actualmente para ensayos de diagnóstico clínico de diagnóstico in vitro.
- Antisera - Antigen - Monoclonal Antibody - Polyclonal Antibody
| Antisera | Source | Application | ||||
| ApoA1 | Goat | TIA | ||||
| ApoB | Goat | TIA | ||||
| PA | Goat | TIA | ||||
| IgA | Goat | TIA | ||||
| IgG | Goat | TIA | ||||
| IgM | Goat | TIA | ||||
| C3 | Goat | TIA | ||||
| C4 | Goat | TIA | ||||
| ApoE | Goat | TIA | ||||
| FIB | Goat | TIA | ||||
| CER | Goat | TIA | ||||
| C1Q | Goat | TIA | ||||
| ALB | Goat | TIA | ||||
| Antigen | Purity | Source | Application | |||||
| NT-proBNP | ≥95% | E.coli, Recombination | POCT,PETIA,CLIA | |||||
| H-FABP | ≥95% | E.coli, Recombination | POCT,PETIA,CLIA | |||||
| PCT | ≥95% | E.coli, Recombination | POCT,PETIA,CLIA | |||||
| β2-MG | ≥95% | E.coli, Recombination | POCT,PETIA,CLIA | |||||
| CysC | ≥95% | E.coli, Recombination | POCT,PETIA,CLIA | |||||
| α1-MG | ≥95% | E.coli, Recombination | POCT,PETIA,CLIA | |||||
| RBP4 | ≥95% | E.coli, Recombination | POCT,PETIA,CLIA | |||||
| MYO | ≥95% | E.coli, Recombination | POCT,PETIA,CLIA | |||||
| PGI | ≥95% | E.coli, Recombination | POCT,PETIA,CLIA | |||||
| PGII | ≥95% | E.coli, Recombination | POCT,PETIA,CLIA | |||||
| IGFBP-1 | ≥95% | E.coli, Recombination | POCT,PETIA,CLIA | |||||
| BNP | ≥95% | Recombination | POCT,PETIA,CLIA | |||||
| C-peptide | ≥95% | Recombination | POCT,PETIA,CLIA | |||||
| Lp-PLA2 | ≥95% | E.coli, Recombination | POCT,PETIA,CLIA | |||||
| CRP | ≥95% | E.coli, Recombination | POCT,PETIA,CLIA | |||||
| D-Dimer | ≥95% | Recombination | POCT,PETIA,CLIA | |||||
| NGAL | ≥95% | Recombination | POCT,PETIA,CLIA | |||||
| SAA | ≥95% | Recombination | POCT,PETIA,CLIA | |||||
| cTnI | ≥95% | Recombination | POCT,PETIA,CLIA | |||||
| ALB | ≥95% | Native | POCT,PETIA,CLIA | |||||
| Monoclonal Antibody | Purity | Source | Application | |||||
| NT-proBNP | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| PCT | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| NGAL | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| Micro-Alb | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| CysC | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| BNP | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| D-D | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| PreS1 | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| cTnl | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| Myo | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| CK-MB | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| IGFBP-1 | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| FFN | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| H-FABP | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| CRP | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| SAA | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| HbA1c | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| Lp-PLA2 | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| PGⅠ | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| PGⅡ | ≥95% | Mouse | POCT,PETIA,CLIA | |||||
| Polyclonal Antibody | Purity | Source | Application | |||||
| CysC | ≥95% | Rabbit | PETIA | |||||
| β2-MG | ≥95% | Rabbit | PETIA | |||||
| α1-MG | ≥95% | Rabbit | PETIA | |||||
| Myo | ≥95% | Goat | PETIA | |||||
| NT-proBNP | ≥95% | Goat | POCT,PETIA | |||||
| CRP | ≥95% | Rabbit | PETIA | |||||
| RBP | ≥95% | Goat | PETIA | |||||
| SAA | ≥95% | Rabbit | PETIA | |||||
| Fer | ≥95% | Goat | PETIA | |||||
| Trans-Fer | ≥95% | Goat | PETIA | |||||
| FDP | ≥95% | Goat | PETIA | |||||
| RBC | ≥95% | Rabbit | POCT | |||||
| NGAL | ≥95% | Goat | PETIA | |||||
